Oxidative stress–CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) are constantly produced in cells, an excess of which causes oxidative stress. ROS has been linked to regulation of the Hippo pathway; however, the underlying detailed mechanisms remain unclear. Here, we report that MOB1, a substrate of MST1/2 and co-activator of LATS1/2 in the canonical Hippo pathway, interacts with and is acetylated at lysine 11 by acetyltransferase CBP and deacetylated by HDAC6. MOB1-K11 acetylation stabilizes itself by reducing its binding capacity with E3 ligase Praja2 and subsequent ubiquitination. MOB1-K11 acetylation increases its phosphorylation and activates LATS1. Importantly, upstream oxidative stress signals promote MOB1 acetylation by suppressing CBP degradation, independent of MST1/2 kinase activity and HDAC6 deacetylation effect, thereby linking oxidative stress to activation of the Hippo pathway. Functionally, the acetylation-deficient mutant MOB1-K11R promotes lung cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo, compared to the wild-type MOB1. Clinically, acetylated MOB1 corresponds to better prediction of overall survival in patients with non-small cell lung cancer. Therefore, as demonstrated, an oxidative stress-CBP regulatory axis controls MOB1-K11 acetylation and activates LATS1, thereby activating the Hippo pathway and suppressing YAP/TAZ nuclear translocation and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“LATS1 co-activator MOB1 is acetylated at K11 by CBP which interrupts MOB’s interaction with E3 ligase Praja2 and stabilizes the protein (Figure 5) [107].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [107]
The cited source says what the claim attributes to it.
In the citing paper
“This mechanism seemingly relies on its difference in deacetylases, LATS1 by SIRT3/4 [104] and MOB1 by HDAC6 [107], to fine tune Hippo/YAP signaling and modulate its function as both a tumor suppressor and tumor driver, again highlighting the issues of using pan KAT/KDAC inhibitors to probe these biological questions.”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 2×
“Once oxidation and antioxidation are out of balance, excessive accumulation of H 2 O 2 causes oxidative stress, subsequently promoting lipid oxidation and DNA damage (30,31).”
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201 · cited 1×
“An analysis, based on 9125 tumors in TCGA database, indicated that the Hippo pathway is one of the eight most frequently “altered” signaling pathways in human cancers, including lung cancer (19).”
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“Furthermore, activated LATS1 / 2 promotes phosphorylation of YAP / TAZ, reduces YAP / TAZ nuclear translocation and inhibits the transcription of downstream target genes (16–18).”
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667 · cited 1×
“MOB1 is an important component of the Hippo signaling pathway and is required for full activation of the Hippo core kinase LATS1 (3,12,57,58).”
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232 · cited 2×
“Furthermore, it was known that deacetylases are classified into two categories: histone deacetylase (HDAC) family and sirtuin (SIRT) family (46,47), the inhibitors of which are tricho-statin A (TSA) and nicotinamide, respectively.”
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Research works printed but not linked: 1
- Cao X.Y., Li C.Q., Xiao S.Y., Tang Y.L., Huang J., Zhao S., Li X.Y., Li J.X., Zhang R.L., Yu W. Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage. Proc. Natl. Acad. Sci. U.S.A. 2017; 114: 687– 692. 28069943 PMC5278485 · DOI
Cited by
Wu, H., Liu, Q., Yang, N., & Xu, S. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.161962 · Cited by 223
Zeng, L., Zhou, C., Xu, W., Huang, Y., Wang, W., Ma, Z., Huang, J., Li, J., Hu, L., Xue, Y., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114941 · Cited by 117
Self-citationHorváth, E., Sólyom, Á., Székely, J., Nagy, E. E., & Popoviciu, H. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216468 · Cited by 127
Oxidative stress is the pivot for PM2.5-induced lung injury
Hou, T., Zhu, L., Wang, Y., & Peng, L. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114362 · Cited by 109
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Tao, L., Zhou, Y., Luo, Y., Qiu, J., Xiao, Y., Zou, J., Zhang, Y., Liu, X., Yang, X., Gou, K., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.59 · Cited by 111
Ma, Z., Ding, Y., Ding, X., Mou, H., Mo, R., & Tan, Q. W. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01725-2 · Cited by 80
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Lv, L., & Zhou, X. (2023) · MedComm · doi:10.1002/mco2.375 · Cited by 58
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00445-w · Cited by 46
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
Sun, Y., Jin, X., Meng, J., Guo, F., Chen, T., Zhao, X., Wu, H., & Ren, D. (2023) · The EMBO Journal · doi:10.15252/embj.2023114558 · Cited by 42
Wang, Y., Liu, X., Jing, H., Ren, H., Xu, S., & Guo, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114327 · Cited by 36
Tian, Y., Shi, H., Zhang, D., Wang, C., Zhao, F., Li, L., Xu, Z., Jiang, J., & Li, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.018 · Cited by 34
Wen, E., Tian, Y., Chen, Y., Wang, Z., Feng, Y., & Liao, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03453-4 · Cited by 30
Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway
Ma, X., Feng, W., Li, N., Chen, S., Zhong, X., Chen, J., Lin, C., & Xu, Q. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155243 · Cited by 26
Wang, X., Li, Y., Tang, Y., Liu, Z., Liu, Y., Fu, X., Guo, S., Ma, J., Ma, F., Zhu, Z., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217901 · Cited by 34
Self-citationAcetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
MST1: A future novel target for cardiac diseases
Shao, Y., Wang, Y., Sun, L., Zhou, S., Xu, J., & Xing, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124296 · Cited by 21
Deciphering the role of Hippo pathway in lung cancer
Ghafouri‐Fard, S., Poornajaf, Y., Hussen, B. M., Avval, S. T., Taheri, M. N., & Mokhtari, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154339 · Cited by 16
Yan, X.-Z., Peng, J., Liu, Y., Fan, R.-N., Ni, X.-Y., Gong, L., Zhang, D., Huang, X., Tan, S., & Wang, H.-L. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108829 · Cited by 19
Zhao, K., Zheng, M., Su, Z., Ghosh, S., Zhang, C., Zhong, W., Ho, J. W. K., Jin, G., & Zhou, Z. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112939 · Cited by 18
Ren, Y., Wu, H., Tan, M., Chen, J., Duan, Z., Zhu, B., Ruan, X., Yu, Q., Li, S., Liu, X., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155152 · Cited by 14
Biswal, P., Sahu, M. R., Ahmad, M. H., & Mondal, A. C. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101885 · Cited by 12
Jin, Y., Hu, C., Xia, J., Xie, D., Ye, L., Ye, X., Li, J., Song, H., Zhu, Y., Jiang, S., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.004 · Cited by 13
Huang, C., Yu, X., Qing, L., Tang, J., & Wu, P. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41632 · Cited by 14
Hu, Z., Tang, M., Huang, Y., Cai, B., Sun, X., Chen, G., Huang, A., Li, X., Shah, A. R., Jiang, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58317-0 · Cited by 15
Self-citationThe Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer
Zhong, B., Du, J., Liu, F., & Sun, S. (2025) · MedComm · doi:10.1002/mco2.70128 · Cited by 12
Jin, F., Ni, X., Yu, S., Jiang, X., Shi, X., Zhou, J. Y., Mao, D., Wang, H., Liu, Y., & Wu, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154761 · Cited by 13
Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review)
Qu, F., Zhao, Q., & Jin, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5578 · Cited by 12
Guo, M., Wang, Y., Shi, J. R., Cao, L., Ou, Y., Jia, X., Qi, C., Li, Z., Liu, Y., Zuo, S., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103834 · Cited by 13
Self-citationXu, Y.-F., Yang, N., Hao, P.-H., Wen, R., & Zhang, T. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00773-z · Cited by 14
Cui, X., Lin, Q., Chen, M., Wang, Y., Wang, Y., Wang, Y., Jiang, T., Yin, H., & Zhao, T. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108174 · Cited by 8
Oxidative stress reprograms the transcriptional coactivator Yki to suppress cell proliferation
Sun, X., Zhou, D., Sun, Y., Zhao, Y., Deng, Y., Pang, X., Liu, Q., & Zhou, Z. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114584 · Cited by 7
The critical role of the Hippo signaling pathway in renal fibrosis
Zhao, C., Wang, H., Xu, C., Fang, F., Gao, L., Zhai, N., Zhong, Y., & Wang, X. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111661 · Cited by 9
Li, Y., Jiang, Y., Yan, H., Qin, Z., Peng, Y., Lv, D., & Zhang, H. (2024) · iScience · doi:10.1016/j.isci.2024.110775 · Cited by 8
Self-citationGiovannetti, F., Pontecorvi, P., Megiorni, F., Armentano, M., Alisi, L., Romano, E., Marchese, C., Lambìase, A., & Bruscolini, A. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.4.80 · Cited by 7
Translocation of SIRT6 promotes glycolysis reprogramming to exacerbate diabetic angiopathy
Pang, K., Huang, J., Zhang, S., Guan, Y., Zou, N., Kang, J., Du, H., Zhao, D., Валерьевич, А. Д., Chen, H., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103736 · Cited by 11
Self-citationToxicological effects and defense mechanisms induced by beta-cypermethrin in Drosophila melanogaster
Xu, G., Long, X., Zhai, J., Liu, Y., Wang, C., Li, J., & Wang, X. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.122845 · Cited by 5
DNA methylation analysis reveals the effect of arsenic on gestational diabetes mellitus
Gao, Y., Wang, H., Fu, G., Feng, Y., Wu, W., Yang, H., Zhang, Y., & Wang, S. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110674 · Cited by 5
Dai, X., Lin, A., Mi, X., Ke, Y., Zhang, J., & Chen, X. (2023) · Neuroendocrinology · doi:10.1159/000528913 · Cited by 5
TAZ upregulates MIR‐224 to inhibit oxidative stress response in multiple myeloma
Abegunde, S. O., Grieve, S., & Reiman, T. (2023) · Cancer Reports · doi:10.1002/cnr2.1879 · Cited by 5
Snhg18 regulates Yap subcellular localization to maintain bone homeostasis
Huang, J., Weng, Y., Feng, Y., Wu, D., Chen, Y., Li, Z., Jiang, X., Wang, H., & Wang, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-62838-z · Cited by 5
HDAC11-Mediated Deacetylation of Triosephosphate Isomerase 1 Promotes Idiopathic Pulmonary Fibrosis
Li, Y., Shi, X., Zhang, F., Zhou, X., Zhu, X., Chen, J., Fu, K., Chen, J., Yang, J., Chen, Z., et al. (2025) · Research · doi:10.34133/research.0953 · Cited by 9
Bi, C. (2024) · American Journal of Cancer Research · doi:10.62347/beuv4081 · Cited by 4
Yang, P., & Li, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1610471 · Cited by 7
Acetylation-dependent USP7-TRIM25 axis drives oncogenic progression in non-small cell lung cancer
Yang, J., Chen, Z., Hu, W., Zeng, W., Lei, Z., Tong, X., Li, Q., Luo, G., Hu, K., Chen, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08034-9 · Cited by 8
Self-citation5-Methylcytosine Methylation-Linked Hippo Pathway Molecular Interactions Regulate Lipid Metabolism
Du, L., Gao, R., & Chen, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062560 · Cited by 4
Zhang, Y., Xiao, Q., Zhou, X., Li, Y., Wang, S., Zhou, X., Chen, R., Zhang, Y., Gao, M., Xu, F., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06974 · Cited by 3
Chen, Y., Jiang, H., Liu, W., Du, Z., Wang, Z., Zhou, Z., & Chi, F. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118703 · Cited by 3
Liu, R., Li, J., Nian, Q., Tu, G., Wang, Z., Zhang, R., & Li, G. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102507 · Cited by 4
Xiao, S., Wang, W., Shi, P., He, K., Peng, C., Zhang, Y., Hong, S., Yang, Y., Feng, J., Bi, H., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157767 · Cited by 3
Reversible acetylation of Hpo regulates the Hippo pathway
Lei, F., Ding, Y., Liu, Y., Li, H., Zhou, D., Ding, W., Liu, B., Sun, X., Wang, X., Zhao, Y., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528243123 · Cited by 3
ROS: their roles in diminished ovarian reserve
Chen, X., & 刘丹卓 (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1823452 · Cited by 5
Jie, H., Luo, L., Cai, B., Xu, Y. K., Yuan, Y., Wen, Y., Liu, S.-M., Tan, J., Chen, M., Zhou, C., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf076 · Cited by 2
Zhang, K., Peng, X., Zhou, P., Li, X., Shen, L., Yang, L., & Zhou, Q. (2025) · Oncogene · doi:10.1038/s41388-025-03471-4 · Cited by 4
Self-citationYang, S., Xie, H.-Y., Lin, Q., Zhou, L., Liu, J., Fang, Z., Tang, Z., Yuan, R., Su, J., Li, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202510508 · Cited by 6
Self-citationSun, Y., Kong, W., Zhu, X., Chu, X., Wang, X., Zhu, G., He, X., & Li, J. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189507 · Cited by 3
Li, F., Shi, Y., Liu, J., Yang, Y., Yan, C., Sun, X., Zhang, Z., Zhang, B., Wang, Q., Du, M., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.11.048 · Cited by 7
A superoxide anion-responsive persulfide prodrug for remedying dry eye disease
Su, M., Zhang, Y., Lv, Z., Zheng, W., Hong, N., Zheng, F., Yao, K., Han, H., Wang, Y., & Ye, P. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114600 · Cited by 2
High-effect synergy from dual HDAC6 and YAP–TEAD inhibition in ovarian clear cell carcinoma
Zaitsu, S., Yano, M., Sakashita, S., Miwa, M., Yasuda, M., Kobayashi, E., & Matsuura, K. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04204-7 · Cited by 2
MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes
Nishio, M., Yamaguchi, K., Otani, J., Yuguchi, K., Kohno, D., Sasaki, T., Kitamura, T., Shinohara, M., Soga, T., Kawamura, K., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424741122 · Cited by 3
Reversible Acetylation of Non-histone Proteins in Human Cancers
Feng, C., Zeng, Y., Prochownik, E. V., Jiang, C., & Li, Y. (2025) · Results and problems in cell differentiation · doi:10.1007/978-3-031-91459-1_13 · Cited by 1
Li, J., Huang, S., Yuan, F., Yang, X., & Xie, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-03339-9 · Cited by 2
Wang, C., Ni, X., Liu, X., Zhang, K., Fan, W., Guo, J., Zhang, M., 魏云海, Zheng, L., Jiang, T., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157821 · Cited by 2
Liu, X., Yang, H., Liu, S., Zhang, Q., Lin, J., Zhan, J., Yuan, L., Yang, M., & Ge, F. (2026) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiag033 · Cited by 2
Self-citationSasse, R., & Mejias-Beck, J. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09986-4 · Cited by 1
Lu, T., Wang, Q., Zhao, M., Chen, L., Dai, C., Tang, H., Guo, Q., & Wang, J. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400027 · Cited by 1
Associations between lipids and lung cancer subtypes
Wen, J., & He, J.-Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-02450-1 · Cited by 1
Milošević, E., Novković, M., Cenni, V., Bavelloni, A., Kojić, S., & Jasnic-Savovic, J. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-024-02272-2
Research Progress on the Mechanism of Massage in Regulating Immune Function
He, Y., Yuan, H., Yu, B., & Yang, L. (2024) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2024.06(08).45
Qing, H., Jiang, X., Ma, Y., Xing, Z., Wu, Y., Wang, K., Cao, H., Jiao, Z., & Yu, Z. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.70030
Wu, L., Song, Z., Zhou, Y., Huang, J., & Huang, X. (2025) · Biomedicines · doi:10.3390/biomedicines13102479
Shi, L., Liu, Y., Tian, Z., Tang, C. Y., Yang, L., Fang, Y., Wang, Y., & Liu, Y. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113282
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583453
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583447
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583441
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583438
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583450
Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26583444
Wang, Z., Liu, S.-Y., Gao, M., Shen, Y., Sun, M., & Hao, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116251 · Cited by 2
OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis
Qu, S., Liu, Z., Wang, B., Li, X., Li, Z., Gai, Y., Sun, Y., Zhang, Q., Sun, Y., Pan, W., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101285 · Cited by 1
Self-citationWang, Z., Liu, S., Gao, M., Shen, Y., Sun, M., & Hao, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116375
Ma, Y., Meng, X., Yin, X., Yu, Y., Lü, S., Gu, W., & Meng, Q. (2026) · Virulence · doi:10.64898/2026.03.02.708988
Lee, B. J., Agarwal, D., Huang, J. H., Ivanova, A., Bu, J. J., Hill, C. A., Noguchi, T., Jun, J. H., Makarenkova, H. P., Wahlin, K. J., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.3.12
Jie, H., Yang, X., Hou, Y., Liang, W., Li, W., Li, Z., Lei, D., Xie, H., Cai, T., Chen, Z., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02804-4
Jiao, F., Ma, M., Peng, L., Luo, X., Tong, M., Yi, T., Long, F., Gao, R., Han, F., He, J., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.022
Targeting YAP: mechanistic breakthroughs and therapeutic prospects in reversing organ fibrosis
Fu, K., Cao, M., Wang, Y., Luo, J., & Yuan, W. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05540-y · Cited by 1
Self-citationZhang, L., Shen, N., Cheng, X., Shi, Q., Chen, L., & Shen, X. X. (2026) · Cancer Science · doi:10.1111/cas.70404
Self-citationTIAL1 regulates the Hippo pathway through an RNA-binding-independent mechanism
Dai, Q., Lou, L., Zhu, X., Zhao, H., Cai, Z., Wei, P., Zhong, Y., 彭舒畅, Hu, X., Sun, R., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03807-8
CircPRKCA Promotes NSCLC Progression via miR-200b-3p/FRMD6/SNAI2 Axis
Zhong, H., Wang, N., Zhang, H., Chen, M., Liao, X., & Huang, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093824
Self-citationFrom bile acids to yes-associated protein: A bidirectional switch for cholangiocarcinoma therapy
Zhang, S.-Y., Yu, H., Mi, Y., & Xiao, F. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i5.117990
Targeting eIF5A combats breast cancer progression by ClpP‐dependent mitochondrial oxidative stress
Zhu, J., Tang, B., Xie, B., Deng, H., Yang, H., Ma, L., Zhang, Z., Ma, Y., Ma, X., Wang, S., et al. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70140
Fu, Y., Zhao, Y., Guo, L., Shi, D., Sun, X., Shang, M., Wang, X., Liu, R., Huang, S., Zhang, X., et al. (2026) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2026.107949
Shu, N.-B., Peng, L., Luo, Y., Wang, Y., Feng, D., Zeng, L., & Tang, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1869028
Zeng, C., Li, Q., Guo, D., Xiong, W., Zou, X., Li, W., Bin, J., Wang, X., Zhang, Z., Xue, B., et al. (2026) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-026-01201-y
Dong, Z., Zhou, Y., Gao, Y., Guo, R., He, X., Deng, Y., Chen, Y., Zhu, Q., Wei, J., & Guo, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1784874
ROS‐ATM‐CBP axis‐mediated PARP1 lactylation aggravates doxorubicin‐induced cardiotoxicity
Wang, W., & Sun, Y. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70745
Interactions between circular RNAs (circRNAs) and the Hippo pathway in cancer
Li, P., Huang, D., & Gu, X. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12721-x · Cited by 1
Wang, Z., Li, C., Zhu, R., Duan, M., Kuang, Z., Li, X., Cui, W., Duan, C., & Zhang, C. (2026) · Autophagy · doi:10.1080/15548627.2026.2728617
Self-citationBone Aging and Glycative Stress: Convergent and Divergent Mechanisms Driving Skeletal Deterioration
Peñarrubia, S., Martín‐Guerrero, E., Gortázar, A. R., & Ardura, J. A. (2026) · Cells · doi:10.3390/cells15181712
Oh, S., Kim, G. E., Oh, M., Oh, S. M., Kim, M. S., Lee, J. I., Son, K. H., & Byun, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188371
Metadata
- Authors
- Jin, J., Zhang, L., Li, X., Xu, W., Yang, S., Song, J., Zhang, W., Zhan, J., Luo, J., & Zhang, H.
- Affiliations
- Peking University (CN)
- Tsinghua University (CN)
- Corresponding author
- Zhang, Hongquan
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-29
- Volume
- 50
- Issue
- 7
- Pages
- 3817-3834
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC9023286
- OpenAlex
- W4221109755
- Cited by
- 99
- References
- 68
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 18 · 2023: 18 · 2022: 1
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of China (2021YFC2501000)
- National Natural Science Foundation of China (81730071, 81972616, 81230051, 81972609, 81773199)
- Beijing Natural Science Foundation (7171005, 7202084)
- Shanghai Science and Technology Commission (20JC1410100)
- Peking University grant (PKU2021LCXQ023)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- MOB1, CBP, oxidative stress, reactive oxygen species, Hippo signaling pathway, lysine acetylation, HDAC6, LATS1, MST1/2, ubiquitination, non-small cell lung cancer, tumor progression, prognostic factors
- MeSH terms
- Hippo Signaling Pathway, Acetylation, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Protein Serine-Threonine Kinases, Reactive Oxygen Species, Oxidative Stress, Chemokine CXCL10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.